Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05424718 · ClinicalTrials.gov registry record · NA

MyPEEPS Mobile for Young Transgender Men

A NA study of HIV, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
80
Enrollment target
3
Study locations

NCT05424718 is a NA study of HIV that has completed, run by Columbia University. The registered enrollment target is 80 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05424718, a NA study of HIV, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
3
Study locations

Study Summary

The proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk youth. The final product will be the basis for conducting a large-scale efficacy study in this population.

Conditions Studied

Interventions

  • BEHAVIORAL MyPEEPS Mobile

Study Locations (3)

New York

  • Callen-Lorde Community Health Center - New York
  • Columbia University - New York

Illinois

  • Ann & Robert H. Lurie Children's Hospital Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-06-16
Est. Completion 2024-03-21
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05424718

The ClinicalTrials.gov registry entry for NCT05424718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (82% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which MyPEEPS Mobile is the first listed.

NCT05424718 reports 3 study locations spanning 2 distinct geographic areas - top geographies include New York, Illinois.

Frequently Asked Questions

What is clinical trial NCT05424718 about?

NCT05424718 is a clinical study titled "MyPEEPS Mobile for Young Transgender Men". The proposed MyPEEPS intervention for young transgender men is a novel and evidence-driven intervention using mobile technology to deliver HIV prevention information to high risk youth. The final product will be the basis for conducting a large-scale efficacy study in this population.

What is the current status of trial NCT05424718?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-06-16. Estimated completion is 2024-03-21.

What conditions does trial NCT05424718 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT05424718?

The interventions under investigation include: MyPEEPS Mobile (BEHAVIORAL).

Who is sponsoring clinical trial NCT05424718?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05424718 being conducted?

This trial has 3 study locations across Illinois, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.